BIOVENTRIX, INC. research brief
CIK 1283259
Generated Nov. 2, 2026, 2:10 p.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.
Current stored business address: MANSFIELD MA. Reported legal jurisdiction: DELAWARE. These do not establish investor residence or where funds were deployed.
- Oct. 8, 2026 · D · 0001283259-26-000005 · Source evidence
Reported offering amount: 3000000 USD. Reported amount sold: 1200000 USD.
- Sept. 9, 2026 · D/A · 0001283259-26-000004 · Source evidence
Reported offering amount: 10000000 USD. Reported amount sold: 2965000 USD.
- Sept. 1, 2026 · D/A · 0001283259-26-000003 · Source evidence
Reported offering amount: 10000000 USD. Reported amount sold: 2765000 USD.
- April 24, 2026 · D · 0001283259-26-000002 · Source evidence
Reported offering amount: 6000000 USD. Reported amount sold: 705000 USD.
- Nov. 4, 2025 · D/A · 0001283259-25-000002 · Source evidence
Reported offering amount: 12000000 USD. Reported amount sold: 6672600 USD.
- July 8, 2025 · D/A · 0001461859-25-000015 · Source evidence
Reported offering amount: 7500000 USD. Reported amount sold: 3602000 USD.
Reviewed offering links
- No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.
Citation: Form D Explorer, “BIOVENTRIX, INC. research brief,” CIK 1283259, retrieved Nov. 2, 2026, 2:10 p.m.. Cite the specific accessions used. No amounts have been summed.